Company: ATIIU
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001437749-25-010221
Chunk: 133

Company: Archimedes Tech SPAC Partners II Co.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 11
Chunk 133
---
OB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
 
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
 
 /s/ WithumSmith+Brown, PC  

We have served as the Company’s auditor since 2024.
 
New York, New York
March 31, 2025
PCAOB ID 100

  F-2

ARCHIMEDES TECH SPAC PARTNERS II CO.

BALANCE SHEET

DECEMBER 31, 2024

    ASSETS     
 Deferred offering costs  $429,691 
 TOTAL ASSETS  $429,691 
     
 LIABILITIES AND SHAREHOLDER’S DEFICIT     
 Current liabilities     
 Accrued expenses  $23,000 
 Accrued offering costs   268,358 
 Promissory note — related party   192,033 
 Total Liabilities   483,391 
     
 Commitments and Contingencies      
     
 Shareholder’s Deficit     
 Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding   — 
 Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 5,750,000 shares issued and outstanding (1)   575 
 Additional paid-in capital   24,425 
 Accumulated deficit   (78,700)
 Total Shareholder’s Deficit   (53,700)
 TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT  $429,691